These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 4743268

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Decreased dopamine and homovanillic acid excretion in a case with chlorpromazine-induced Parkinsonism.
    Messiha FS, Turek I.
    Res Commun Chem Pathol Pharmacol; 1973 Jul; 6(1):329-30. PubMed ID: 4734007
    [No Abstract] [Full Text] [Related]

  • 23. Dopamine and dopamine metabolites in Parkinson's disease-a review.
    Barbeau A.
    Proc Aust Assoc Neurol; 1968 Jul; 5(1):95-100. PubMed ID: 4885282
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Amantadine hydrochloride in treatment of Parkinsonism.
    Nagaswami S, Nagaswami R.
    Dis Nerv Syst; 1973 Jul; 34(5):253-8. PubMed ID: 4782280
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Urinary catecholamine excretion by healthy children. I. Daily excretion of dopamine, norepinephrine, epinephrine, and 3-methoxy-4-hydroxymandelic acid.
    Voorhess ML.
    Pediatrics; 1967 Feb; 39(2):252-7. PubMed ID: 6017961
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Pathogenesis and animal studies of Parkinson's disease.
    Oertel WH, Kupsch A.
    Curr Opin Neurol Neurosurg; 1993 Jun; 6(3):323-32. PubMed ID: 8507901
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Incidence of idiopathic and secondary Parkinson disease in Navarre. Population-based case registry].
    Viñes JJ, Larumbe R, Gaminde I, Artázcoz MT.
    Neurologia; 1999 Jan; 14(1):16-22. PubMed ID: 10079687
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Environmental, medical, and family history risk factors for Parkinson's disease: a New England-based case control study.
    Taylor CA, Saint-Hilaire MH, Cupples LA, Thomas CA, Burchard AE, Feldman RG, Myers RH.
    Am J Med Genet; 1999 Dec 15; 88(6):742-9. PubMed ID: 10581500
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Heredity in Parkinson's disease: new findings.
    Lev N, Melamed E.
    Isr Med Assoc J; 2001 Jun 15; 3(6):435-8. PubMed ID: 11433638
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.